Hesham AbdullahSector leader
GSK's global head of cancer research and development
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“Treatment of gynaecological cancers remains a major challenge, with a pressing need for new therapies that offer improved response rates. With Mo-Rez we now have compelling evidence of a promising clinical profile.”
GSK's global head of cancer research and development · Cancer · 27 Aug 2026 · GSK reports promising early results in ovarian and womb cancer drug trial ↗
Source references
- GSK reports promising early results in ovarian and womb cancer drug trialtheguardian.com · 27 Aug 2026
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.